47 related articles for article (PubMed ID: 25794805)
1. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.
Zhou X; Fu Y; Chen J; Liu P
J Ethnopharmacol; 2024 Jun; 327():118018. PubMed ID: 38453100
[TBL] [Abstract][Full Text] [Related]
2. Integrated pharmacokinetic properties and tissue distribution of multiple active constituents in Qing-Yi Recipe: A comparison between granules and decoction.
Ma S; Wei T; Zhang B; Zhang Y; Lai J; Qu J; Liu J; Yin P; Shang D
Phytomedicine; 2024 Jul; 129():155645. PubMed ID: 38643714
[TBL] [Abstract][Full Text] [Related]
3. Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis.
Dong S; Chen QL; Su SB
Evid Based Complement Alternat Med; 2015; 2015():125659. PubMed ID: 26221168
[TBL] [Abstract][Full Text] [Related]
4. Protection of schisantherin A against dictamnine-induced hepatotoxicity: Pharmacokinetic insights.
Chang X; Li G; Yang B; Lin D
J Appl Toxicol; 2024 Apr; 44(4):501-509. PubMed ID: 37873635
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Fuzheng Huayu capsule on inhibiting the fibrosis-associated hepatocellular carcinogenesis.
Zhang WQ; Sun JX; Lan ST; Sun XM; Guo YJ; Wen BC; Chen J; Liu G
J Asian Nat Prod Res; 2024 May; ():1-20. PubMed ID: 38780602
[TBL] [Abstract][Full Text] [Related]
6. Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism.
Li QY; Guo ZZ; Deng X; Xu LM; Gao YQ; Zhang W; Wang XS; Xue DY; Lu YY; Liu P; Su SB
Evid Based Complement Alternat Med; 2013; 2013():302131. PubMed ID: 24282434
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, tissue distribution, and subacute toxicity of oral carrageenan in mice.
Wang J; Zhu K; Zhang M; Zhou Q; Ji W; Yao Z; Li D
Int J Biol Macromol; 2024 May; 266(Pt 1):130725. PubMed ID: 38490394
[TBL] [Abstract][Full Text] [Related]
8. Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1.
Zhang M; Liu HL; Huang K; Peng Y; Tao YY; Zhao CQ; Hu XD; Liu CH
Evid Based Complement Alternat Med; 2020; 2020():8591892. PubMed ID: 33293994
[TBL] [Abstract][Full Text] [Related]
9. Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis.
Liu HL; Lv J; Zhao ZM; Xiong AM; Tan Y; Glenn JS; Tao YY; Weng HL; Liu CH
Sci Rep; 2019 Dec; 9(1):18719. PubMed ID: 31822697
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Yang T; Liu S; Wang CH; Tao YY; Zhou H; Liu CH
J Pharm Biomed Anal; 2015 Oct; 114():152-8. PubMed ID: 26048667
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of eight analytes of Fuzheng Huayu recipe in beagle dog plasma by UHPLC-Q/exactive Orbitrap HRMS and its application to toxicokinetics.
Wang YL; Yang MJ; Li RS; Hu YQ; Pan YF; Yang T
Biomed Chromatogr; 2022 Apr; 36(4):e5329. PubMed ID: 34997600
[TBL] [Abstract][Full Text] [Related]
12. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
Chan YT; Wang N; Tan HY; Li S; Feng Y
Front Pharmacol; 2020; 11():548. PubMed ID: 32425789
[TBL] [Abstract][Full Text] [Related]
13. Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats.
Yang T; Zheng TH; Zhao Q; Liu W; Li SP; Tao YY; Wang CH; Liu CH
Pharm Biol; 2020 Dec; 58(1):1-7. PubMed ID: 31847670
[No Abstract] [Full Text] [Related]
14. The components data of fuzheng huayu extracts,
Liu W; Li Z; Sun Z; Xu Y; Wang S; Hu Y; Peng J
Data Brief; 2019 Aug; 25():104087. PubMed ID: 31294053
[TBL] [Abstract][Full Text] [Related]
15. Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats.
Wang Y; Xing X; Cao Y; Zhao L; Sun S; Chen Y; Chai Y; Chen S; Zhu Z
Evid Based Complement Alternat Med; 2018; 2018():3239785. PubMed ID: 30519262
[TBL] [Abstract][Full Text] [Related]
16. Schizandrin B inhibits the cis‑DDP‑induced apoptosis of HK‑2 cells by activating ERK/NF‑κB signaling to regulate the expression of survivin.
Liu Q; Song J; Li H; Dong L; Dai S
Int J Mol Med; 2018 Apr; 41(4):2108-2116. PubMed ID: 29393335
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administration.
Liu W; Wang X; Chen R; Zhang K; Li Y; Li Y; Si D; Gong J; Yin D; Wang Y; Wei Z; Yang M
Acta Pharm Sin B; 2016 Sep; 6(5):468-474. PubMed ID: 27709016
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Current Status of Evaluation System of Bioavailability and Related Pharmaceutical Technologies for Traditional Chinese Medicines--Flos Lonicerae Japonicae--Fructus Forsythiae Herb Couples as an Example.
Zhou W; Cai B; Shan J; Wang S; Di L
Int J Mol Sci; 2015 Dec; 16(12):28812-40. PubMed ID: 26690115
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Yang T; Liu S; Zheng TH; Tao YY; Liu CH
J Ethnopharmacol; 2015 May; 166():305-12. PubMed ID: 25794805
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
